Germany's Greens propose pharmaceutical sector savings through pricing reforms, while political figures advocate stronger support for pharmacies and coordinated healthcare delivery.
As Germany's statutory health insurance system struggles financially, debates about the fairness and impact of high pharmaceutical prices focus on balancing innovation and affordability.
The German pharmacy sector criticizes the delay in the promised fixed fee increase, calling for urgent action from the government.
The EU is grappling with ongoing medication shortages, prompting health officials to take action.